[Adler JT, Meyer-Rochow GY, Chen H, Benn DE, Robinson BG, Sippel RS, Sidhu SB. Pheochromocytoma: current approaches and future directions. Oncologist 13, 779–793, 2008.10.1634/theoncologist.2008-004318617683]Open DOISearch in Google Scholar
[Ahlawat SK, Jain S, Kumari S, Varma S, Sharma BK. Pheochromocytoma associated with pregnancy: case report and review of the literature. Obstet Gynecol Surv 54, 728–737, 1999.10.1097/00006254-199911000-0002510546277]Open DOISearch in Google Scholar
[Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, Bertagna X, Schlumberger M, Jeunemaitre X, Gimenez-Roqueplo AP, Plouin PF. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab 92, 3822–3828, 2007.10.1210/jc.2007-07091765221217652212]Open DOISearch in Google Scholar
[Amar L, Fassnacht M, Gimenez-Roqueplo A, Januszewicz A, Prejbisz A, Timmers H, Plouin PF. Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma. Horm Metab Res 44, 385–389, 2012.2235147810.1055/s-0031-130133922351478]Search in Google Scholar
[Andrade MO, Cunha VSD, Oliveira DC, Moraes OL, Lofrano-Porto A. What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature. Arch Endocrinol Metab 62, 264–269, 2018.10.20945/2359-399700000003329768630]Search in Google Scholar
[Arnaldi G, Boscaro M. Adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab 26, 405–419, 2012.10.1016/j.beem.2011.12.00622863384]Open DOISearch in Google Scholar
[Baguet JP, Hammer L, Mazzuco TL, Chabre O, Mallion JM, Sturm N, Chaffanjon P. Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol 150, 681–686, 2004.10.1530/eje.0.150068115132724]Search in Google Scholar
[Baudin E. Treatment of malignant pheochromocytomas and paragangliomas. Endocrine Abstracts 32, S14.3, 2013.10.1530/endoabs.32.S14.3]Search in Google Scholar
[Bausch B, Wellner U, Bausch D, Schiavi F, Barontini M, Sanso G, Walz MK, Peczkowska M, Weryha G, Dall’igna P, Cecchetto G, Bisogno G, Moeller LC, Bockenhauer D, Patocs A, Racz K, Zabolotnyi D, Yaremchuk S, Dzivite-Krisane I, Castinetti F, Taieb D, Malinoc A, von Dobschuetz E, Roessler J, Schmid KW, Opocher G, Eng C, Neumann HP. Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer 21, 17–25, 2013.10.1530/ERC-13-041524169644]Open DOISearch in Google Scholar
[Bausch B, Tischler AS, Schmid KW, Leijon H, Eng C, Neumann HPH. Max Schottelius: pioneer in pheochromocytoma. J Endocr Soc 1, 957–964, 2017.10.1210/js.2017-00208568915029264546]Search in Google Scholar
[Bayley JP, Kunst HP, Cascon A, Sampietro ML, Gaal J, Korpershoek E, Hinojar-Gutierrez A, Timmers HJ, Hoefsloot LH, Hermsen MA, Suarez C, Hussain AK, Vriends AH, Hes FJ, Jansen JC, Tops CM, Corssmit EP, de Knijff P, Lenders JW, Cremers CW, Devilee P, Dinjens WN, de Krijger RR, Robledo M. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol 11, 366–372, 2010.10.1016/S1470-2045(10)70007-3]Open DOISearch in Google Scholar
[Bednarczuk T, Bolanowski M, Sworczak K, Gornicka B, Cieszanowski A, Otto M, Ambroziak U, Pachucki J, Kubicka E, Babinska A, Koperski L, Januszewicz A, Prejbisz A, Gorska M, Jarząb B, Hubalewska-Dydejczyk A, Glinicki P, Ruchała M, Kasperlik-Zaluska A. Adrenal incidentaloma in adults - management recommendations by the Polish Society of Endocrinology. Endokrynol Pol 67, 234–258, 2016.10.5603/EP.a2016.003927082051]Search in Google Scholar
[Bessell-Browne R, O’Malley ME. CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material. AJR Am J Roentgenol 188, 970–974, 2007.10.2214/AJR.06.082717377032]Search in Google Scholar
[Bholah R, Bunchman TE. Review of pediatric pheochromocytoma and paraganglioma. Front Pediatr 5, 155, 2017.10.3389/fped.2017.00155550801528752085]Search in Google Scholar
[Biggar MA, Lennard TW. Systematic review of phaeochromocytoma in pregnancy. Br J Surg 100, 182–190, 2013.10.1002/bjs.897623180595]Search in Google Scholar
[Bjorklund P, Pacak K, Crona J. Precision medicine in pheochromocytoma and paraganglioma: current and future concepts. J Intern Med 280, 559–573, 2016.10.1111/joim.12507744182527165774]Search in Google Scholar
[Blake MA, Krishnamoorthy SK, Boland GW, Sweeney AT, Pitman MB, Harisinghani M, Mueller PR, Hahn PF. Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR Am J Roentgenol 181, 1663–1668, 2003.10.2214/ajr.181.6.181166314627592]Search in Google Scholar
[PDQ Adult Treatment Editorial Board. Pheochromocytoma and Paraganglioma Treatment (PDQ®): Health Professional Version. 2018 Feb 8. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK65873/.]Search in Google Scholar
[Bowerman RA, Silver TM, Jaffe MH, Stuck KJ, Hinerman DL. Sonography of adrenal pheochromocytomas. AJR Am J Roentgenol 137, 1227–1231, 1981.10.2214/ajr.137.6.12276976097]Search in Google Scholar
[Bozin M, Lamb A, Putra LJ. Pheochromocytoma with negative metanephrines: A rarity and the significance of dopamine secreting tumors. Urol Case Rep 12, 51–53, 2017.10.1016/j.eucr.2017.02.002536213628337414]Search in Google Scholar
[Briere JJ, Favier J, Benit P, El Ghouzzi V, Lorenzato A, Rabier D, Di Renzo MF, Gimenez-Roqueplo AP, Rustin P. Mitochondrial succinate is instrumental for HIF1a nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions. Hum Mol Genet 14, 3263–3269, 2005.10.1093/hmg/ddi35916195397]Open DOISearch in Google Scholar
[Brito JP, Asi N, Gionfriddo MR, Norman C, Leppin AL, Zeballos-Palacios C, Undavalli C, Wang Z, Domecq JP, Prustsky G, Elraiyah TA, Prokop LJ, Montori VM, Murad MH. The incremental benefit of functional imaging in pheochromocytoma/paraganglioma: a systematic review. Endocrine 50, 176–186, 2015.10.1007/s12020-015-0544-725663601]Search in Google Scholar
[Brunaud L, Boutami M, Nguyen-Thi PL, Finnerty B, Germain A, Weryha G, Fahey TJ 3rd, Mirallie E, Bresler L, Zarnegar R. Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery 156, 1410–1418, 2014.10.1016/j.surg.2014.08.02225456922]Search in Google Scholar
[Brunt LM, Doherty GM, Norton JA, Soper NJ, Quasebarth MA, Moley JF. Laparoscopic adrenalectomy compared to open adrenalectomy for benign adrenal neoplasms. J Am Coll Surg 183, 1–10, 1996.]Search in Google Scholar
[Bruynzeel H, Feelders RA, Groenland TH, van den Meiracker AH, van Eijck CH, Lange JF, de Herder WW, Kazemier G. Risk Ffactors for hemodynamic instability during surgery for pheochromocytoma. J Clin Endocrinol Metab 95, 678–685, 2010.10.1210/jc.2009-105119965926]Search in Google Scholar
[Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL. Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 95, 1196–1204, 2003.10.1093/jnci/djg02412928344]Search in Google Scholar
[Burgess GE 3rd. Alpha blockade and surgical intervention of pheochromocytoma in pregnancy. Obstet Gynecol 53, 266–270, 1979.]Search in Google Scholar
[Burnichon N, Abermil N, Buffet A, Favier J, Gimenez-Roqueplo AP. The genetics of paragangliomas. Eur Ann Otorhinolaryngol Head Neck Dis 129, 315–318, 2012.10.1016/j.anorl.2012.04.00723078982]Search in Google Scholar
[Burnichon N, Buffet A, Gimenez-Roqueplo AP. Pheochromocytoma and paraganglioma: molecular testing and personalized medicine. Curr Opin Oncol 28, 5–10, 2016.10.1097/CCO.000000000000024926599293]Open DOISearch in Google Scholar
[Castinetti F. Outcome of adrenal sparing surgery in heritable pheochromocytoma: the example of multiple endocrine neoplasia type 2. Endocrine Abstracts 37, S12.3, 2015.10.1530/endoabs.37.S12.3]Search in Google Scholar
[Castro-Vega LJ, Buffet A, De Cubas AA, Cascon A, Menara M, Khalifa E, Amar L, Azriel S, Bourdeau I, Chabre O, Curras-Freixes M, Franco-Vidal V, Guillaud-Bataille M, Simian C, Morin A, Leton R, Gomez-Grana A, Pollard PJ, Rustin P, Robledo M, Favier J, Gimenez-Roqueplo AP. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Hum Mol Genet 23, 2440–2446, 2014.10.1093/hmg/ddt63924334767]Open DOISearch in Google Scholar
[Chang A, Glazer HS, Lee JK, Ling D, Heiken JP. Adrenal gland: MR imaging. Radiology 163, 123–128, 1987.10.1148/radiology.163.1.38234233823423]Search in Google Scholar
[Cheah WK, Clark OH, Horn JK, Siperstein AE, Duh Q. Laparoscopic adrenalectomy for pheochromocytoma. World J Surg 26, 1048–1051, 2002.10.1007/s00268-002-6669-x12045856]Open DOISearch in Google Scholar
[Chen H, Sippel RS, O’Dorisio MS, Vinik AI, Lloyd RV, Pacak K; North American Neuroendocrine Tumor Society (NANETS). The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 39, 775–783, 2010.10.1097/MPA.0b013e3181ebb4f0341900720664475]Search in Google Scholar
[Chen Y, Hodin RA, Pandolfi C, Ruan DT, McKenzie TJ. Hypoglycemia after resection of pheochromocytoma. Surgery 156, 1404–1409, 2014.10.1016/j.surg.2014.08.02025456920]Search in Google Scholar
[Cho YY, Suh S, Joung JY, Jeong H, Je D, Yoo H, Park TK, Min YK, Kim KW, Kim JH. Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas. Korean J Intern Med 28, 557–564, 2013.10.3904/kjim.2013.28.5.55724009451375976124009451]Open DOISearch in Google Scholar
[Choi EK, Kim WH, Park KY. A case of a composite adrenal medullary tumor of pheochromocytoma and ganglioneuroma masquerading as acute pancreatitis. Korean J Intern Med 21, 141–145, 2006.1691344710.3904/kjim.2006.21.2.141389073916913447]Search in Google Scholar
[Chrisoulidou A, Kaltsas G, Ilias I, Grossman AB. The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr Relat Cancer 14, 569–585, 2007.10.1677/ERC-07-007417914089]Open DOISearch in Google Scholar
[Comstock JM, Willmore-Payne C, Holden JA, Coffin CM. Composite pheochromocytoma: a clinicopathologic and molecular comparison with ordinary pheochromocytoma and neuroblastoma. Am J Clin Pathol 132, 69–73, 2009.10.1309/AJCPN76VTIGWPOAG19864235]Search in Google Scholar
[Crona J, Delgado Verdugo A, Maharjan R, Stålberg P, Granberg D, Hellman P, Bjorklund P. Somatic mutations in HRAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing. J Clin Endocrinol Metab 98, E1266–E1271, 2013.10.1210/jc.2012-425723640968]Open DOISearch in Google Scholar
[Crona J, Taieb D, Pacak K. New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification. Endocr Rev 38, 489–515, 2017.10.1210/er.2017-00062571682928938417]Open DOISearch in Google Scholar
[Dahia PL. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer 14, 108–119, 2014.10.1038/nrc364824442145]Open DOISearch in Google Scholar
[Dahia PL. Pheochromocytomas and paragangliomas, genetically diverse and minimalist, all at once! Cancer Cell 31, 159–161, 2017.10.1016/j.ccell.2017.01.0092819658728196587]Open DOISearch in Google Scholar
[Dean RE. Pheochromocytoma and pregnancy. Obstet Gynecol 11, 35–42, 1958.]Search in Google Scholar
[Delellis RA, Lloyd RV, Heitx PU. Pathology and genetics of tumors of endocrine organs. In World Health Organization of Tumours. IARC, Lyon, pp. 73–76, 2004.]Search in Google Scholar
[Desmonts JM, Marty J. Anaesthetic management of patients with phaeochromocytoma. Br J Anaesth 56, 781–789, 1984.637570810.1093/bja/56.7.7816375708]Search in Google Scholar
[Dunnick NR, Korobkin M. Imaging of adrenal incidentalomas: current status. AJR Am J Roentgenol 179, 559–568, 2002.10.2214/ajr.179.3.179055912185019]Search in Google Scholar
[Dunwoodie SL. The role of hypoxia in development of the Mammalian embryo. Dev Cell 17, 755–773, 2009.2005994710.1016/j.devcel.2009.11.00820059947]Search in Google Scholar
[Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR, Pacak K. Biochemical diagnosis of pheochromocytoma: how to distinguish true-from false-positive test results. J Clin Endocrinol Metab 88, 2656–2666, 2003.10.1210/jc.2002-0300051278887012788870]Open DOISearch in Google Scholar
[Eisenhofer G, Lenders JW, Pacak K. Biochemical diagnosis of pheochromocytoma. Front Horm Res 31, 76–106, 2004a.10.1159/00007465914674306]Search in Google Scholar
[Eisenhofer G, Bornstein SR, Brouwers FM, Cheung NK, Dahia PL, de Krijger RR, Giordano TJ, Greene LA, Goldstein DS, Lehnert H, Manger WM, Maris JM, Neumann HP, Pacak K, Shulkin BL, Smith DI, Tischler AS, Young WF Jr. Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 11, 423–436, 2004b.10.1677/erc.1.0082915369446]Open DOISearch in Google Scholar
[Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT, Pacak K. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90, 2068–2075, 2005.1564439710.1210/jc.2004-202515644397]Search in Google Scholar
[Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem 57, 411–420, 2011.2126295110.1373/clinchem.2010.153320316499821262951]Search in Google Scholar
[Eisenhofer G, Lenders JW, Siegert G, Bornstein SR, Friberg P, Milosevic D, Mannelli M, Linehan WM, Adams K, Timmers HJ, Pacak K. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer 48, 1739–1749, 2012.10.1016/j.ejca.2011.07.016337262422036874]Open DOISearch in Google Scholar
[Eisenhofer G, Prejbisz A, Peitzsch M, Pamporaki C, Masjkur J, Rogowski-Lehmann N, Langton K, Tsourdi E, Pęczkowska M, Fliedner S, Deutschbein T, Megerle F, Timmers HJLM, Sinnott R, Beuschlein F, Fassnacht M, Januszewicz A, Lenders JWM. Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-methylated catecholamine metabolites. Clin Chem 64, 1646–1656, 2018.10.1373/clinchem.2018.2913693009749830097498]Open DOISearch in Google Scholar
[Elder EE, Elder G, Larsson C. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol 89, 193–201, 2005.10.1002/jso.2017715719371]Search in Google Scholar
[Elsayes KM, Mukundan G, Narra VR, Lewis JS Jr, Shirkhoda A, Farooki A, Brown JJ. Adrenal masses: MR imaging features with pathologic correlation. Radiographics 24, S73–S86, 2004.10.1148/rg.24si04551415486251]Open DOISearch in Google Scholar
[Evenepoel L, Papathomas TG, Krol N, Korpershoek E, de Krijger RR, Persu A, Dinjens WN. Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations. Genet Med 17, 610–620, 2015.10.1038/gim.2014.1622539417625394176]Open DOISearch in Google Scholar
[Farrugia FA, Georgios M, Panagiotis T, Nikolaos Z, Anestis C, Dimitrios S, Nikolaoes K, Anna P, Erini K, Machairas A. Adrenal incidentaloma or epinephroma and review of the literature. Differential diagnosis of adrenal incidentaloma. Khirurgiia 82, 120–128, 2016.]Search in Google Scholar
[Farrugia FA. “Ephidrosis,” Is a New Term to Replace the Term “Diaphoresis” J Ren Nutr 27, 445, 2017.10.1053/j.jrn.2017.08.00929056161]Search in Google Scholar
[Farrugia FA, Martikos G, Tzanetis P, Charalampopoulos A, Misiakos E, Zavras N, Sotiropoulos D. Pheochromocytoma, diagnosis and treatment: Review of the literature. Endocr Regul 51, 168–181, 2017.10.1515/enr-2017-001828858847]Search in Google Scholar
[Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol 11, 101–111, 2015.10.1038/nrendo.2014.18825385035]Open DOISearch in Google Scholar
[Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS; Cancer Genome Atlas Research Network, Pacak K, Nathanson KL, Wilkerson MD. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31, 181–193, 2017.10.1016/j.ccell.2017.01.001564315928162975]Open DOISearch in Google Scholar
[Flynn A, Benn D, Clifton-Bligh R, Robinson B, Trainer AH, James P, Hogg A, Waldeck K, George J, Li J, Fox SB, Gill AJ, McArthur G, Hicks RJ, Tothill RW. The genomic landscape of phaeochromocytoma. J Pathol 236, 78–89, 2015.10.1002/path.450325545346]Search in Google Scholar
[Francis IR, Korobkin M. Pheochromocytoma. Radiol Clin North Am 34, 1101–1112, 1996.10.1016/S0033-8389(22)00693-5]Search in Google Scholar
[Gagner M, Lacroix A, Bolte E. Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma. N Engl J Med 327, 1033, 1992.10.1056/NEJM1992100132714171387700]Search in Google Scholar
[Gagner M, Pomp A, Heniford BT, Pharand D, Lacroix A. Laparoscopic adrenalectomy: lessons learned from 100 consecutive procedures. Ann Surg 226, 238–247, 1997.10.1097/00000658-199709000-0000311910159339930]Search in Google Scholar
[Galati SJ, Said M, Gospin R, Babic N, Brown K, Geer EB, Kostakoglu L, Krakoff LR, Leibowitz AB, Mehta L, Muller S, Owen RP, Pertsemlidis DS, Wilck E, Xiao GQ, Levine AC, Inabnet WB 3rd. The Mount Sinai clinical pathway for the management of pheochromocytoma. Endocr Pract 21, 368–382, 2015.10.4158/EP14036.RA25297659]Open DOISearch in Google Scholar
[Giannini AJB, Henry R, Goettsche, Roger L. Psychiatric, Psychogenic and Somatopsychic Disorders Handbook. M. Examination. Garden City, NY, 1978.]Search in Google Scholar
[Goffredo P, Sosa JA, Roman SA. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades. J Surg Oncol 107, 659–664, 2013.10.1002/jso.2329723233320]Search in Google Scholar
[Goldstein M, Fuxe K, Hokfelt T. Characterization and tissue localization of catecholamine synthesizing enzymes. Pharmacol Rev 24, 293–309, 1972.4564603]Search in Google Scholar
[Goldstein RE, O’Neill JA Jr, Holcomb GW 3rd, Morgan WM 3rd, Neblett WW 3rd, Oates JA, Brown N, Nadeau J, Smith B, Page DL, Abumrad NN, Scott HW Jr. Clinical experience over 48 years with pheochromocytoma. Ann Surg 229, 755–766, 1999.10.1097/00000658-199906000-00001142082110363888]Search in Google Scholar
[Graham JB. Pheochromocytoma and hypertension; an analysis of 207 cases. Int Abstr Surg 92, 105–121, 1951.]Search in Google Scholar
[Gregory SH, Yalamuri SM, McCartney SL, Shah SA, Sosa JA, Roman S, Colin BJ, Lentschener C, Munroe R, Patel S, Feinman JW, Augoustides JG. Perioperative management of adrenalectomy and inferior vena cava reconstruction in a patient with a large, malignant pheochromocytoma with vena caval extension. J Cardiothorac Vasc Anesth 31, 365–377, 2017.10.1053/j.jvca.2016.07.01927810406]Search in Google Scholar
[Groeben H, Nottebaum BJ, Alesina PF, Traut A, Neumann HP, Walz MK. Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth 118, 182–189, 2017.2810052110.1093/bja/aew39228100521]Search in Google Scholar
[Grubbs EG, Rich TA, Ng C, Bhosale PR, Jimenez C, Evans DB, Lee JE, Perrier ND. Long-term outcomes of surgical treatment for hereditary pheochromocytoma. J Am Coll Surg 216, 280–289, 2013.10.1016/j.jamcollsurg.2012.10.01223317575]Search in Google Scholar
[Guerrero MA, Schreinemakers JM, Vriens MR, Suh I, Hwang J, Shen WT, Gosnell J, Clark OH, Duh QY. Clinical spectrum of pheochromocytoma. J Am Coll Surg 209, 727–732, 2009.10.1016/j.jamcollsurg.2009.09.02219959041]Search in Google Scholar
[Gunawardane PTK, Grossman A. Phaeochromocytoma and paraganglioma. In: Hypertension: from basic research to clinical practice, Vol. 2, (Ed. Md. Shahidul Islam), Springer, pp. 239–259, 2017.10.1007/5584_2016_7627888488]Search in Google Scholar
[Gut P, Czarnywojtek A, Fischbach J, Baczyk M, Ziemnicka K, Wrotkowska E, Gryczynska M, Ruchala M. Chromogranin A - unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls. Arch Med Sci 12, 1–9, 2016.10.5114/aoms.2016.57577475436426925113]Search in Google Scholar
[Hack HA. The perioperative management of children with phaeochromocytoma. Paediatr Anaesth 10, 463–476, 2000.1101294910.1046/j.1460-9592.2000.00504.x11012949]Search in Google Scholar
[Halkertson IDK. A Wiley Medical Publication: Biochemistry, John Wiley & Sons, 1988.]Search in Google Scholar
[Harari A, Inabnet WB 3rd. Malignant pheochromocytoma: a review. Am J Surg 201, 700–708, 2011.10.1016/j.amjsurg.2010.04.01220870212]Search in Google Scholar
[Harrington JL, Farley DR, van Heerden JA, Ramin KD. Adrenal tumors and pregnancy. World J Surg 23, 182–186, 1999.10.1007/PL000131599880429]Open DOISearch in Google Scholar
[Havekes B, Lai EW, Corssmit EP, Romijn JA, Timmers HJ, Pacak K. Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging 52, 419–429, 2008.]Search in Google Scholar
[Havekes B, King K, Lai EW, Romijn JA, Corssmit EP, Pacak K. New imaging approaches to phaeochromocytomas and paragangliomas. Clin Endocrinol (Oxf) 72, 137–145, 2010.10.1111/j.1365-2265.2009.03648.x296697319508681]Open DOISearch in Google Scholar
[Hickman PE, Leong M, Chang J, Wilson SR, McWhinney B. Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma. Pathology 41, 173–177, 2009.10.1080/003130208025792841915219019152190]Open DOISearch in Google Scholar
[Hofer M. Ultrasound Teaching Manual. The Basics of Performing and Interpreting Ultrasound Scans. Thieme Stuttgart, New York, 1999.]Search in Google Scholar
[Hrascan R, Pecina-Slaus N, Martic TN, Colic JF, Gall-Troselj K, Pavelic K, Karapandza N Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas. J Neuroendocrinol 20, 1015–1022, 2008.10.1111/j.1365-2826.2008.01755.x18510707]Open DOISearch in Google Scholar
[Huang LE, Bindra RS, Glazer PM, Harris AL. Hypoxia-induced genetic instability-a calculated mechanism underlying tumor progression. J Mol Med (Berl) 85, 139–148, 2007.10.1007/s00109-006-0133-617180667]Search in Google Scholar
[Huang D, Li C, Zhang H. Hypoxia and cancer cell metabolism. Acta Biochim Biophys Sin (Shanghai) 46, 214–219, 2014.10.1093/abbs/gmt14824389642]Search in Google Scholar
[Ilias I, Pacak K. Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 89, 479–491, 2004.10.1210/jc.2003-03109114764749]Search in Google Scholar
[Jaroszewski DE, Tessier DJ, Schlinkert RT, Grant CS, Thompson GB, van Heerden JA, Farley DR, Smith SL, Hinder RA. Laparoscopic adrenalectomy for pheochromocytoma. Mayo Clin Proc 78, 1501–1504, 2003.10.4065/78.12.150114661679]Open DOISearch in Google Scholar
[Jimenez C, Waguespack SG. Functional imaging for pheochromocytoma-paraganglioma: a step closer to understanding its place in clinical practice. Endocrine 50, 6–8, 2015.10.1007/s12020-015-0672-026113425]Search in Google Scholar
[Jochmanova I, Yang C, Zhuang Z, Pacak K. Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst 105, 1270–1283, 2013.10.1093/jnci/djt201388827923940289]Search in Google Scholar
[Jochmanova I, Pacak K. Pheochromocytoma: the first metabolic endocrine cancer. Clin Cancer Res 22, 5001–5011, 2016.10.1158/1078-0432.CCR-16-0606507408627742786]Open DOISearch in Google Scholar
[Juarez D, Brown RW, Ostrowski M, Reardon MJ, Lechago J, Truong LD. Pheochromocytoma associated with neuroendocrine carcinoma. A new type of composite pheochromocytoma. Arch Pathol Lab Med 123, 1274–1279, 1999.10.5858/1999-123-1274-PAWNC10583935]Search in Google Scholar
[Karvonen H, Perttila R, Niininen W, Barker H, Ungureanu D. Targeting Wnt signaling pseudokinases in hematological cancers. Eur J Haematol 101, 457–465, 2018.10.1111/ejh.1313729989208]Search in Google Scholar
[Katoh M, Katoh M. Molecular genetics and targeted therapy of WNT-related human diseases. Int J Mol Med 40, 587–606, 2017.2873114810.3892/ijmm.2017.3071554794028731148]Search in Google Scholar
[Kawashima A, Sandler CM, Ernst RD, Takahashi N, Roubidoux MA, Goldman SM, Fishman EK, Dunnick NR. Imaging of nontraumatic hemorrhage of the adrenal gland. Radiographics 19, 949–963, 1999.10.1148/radiographics.19.4.g99jl1394910464802]Open DOISearch in Google Scholar
[Keith B, Johnson RS, Simon MC. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 12, 9–22, 2012.10.1038/nrc3183340191222169972]Open DOISearch in Google Scholar
[Kenchegowda D, Natale B, Lemus MA, Natale DR, Fisher SA. Inactivation of maternal Hif-1α at mid-pregnancy causes placental defects and deficits in oxygen delivery to the fetal organs under hypoxic stress. Dev Biol 422, 171–185, 2017.10.1016/j.ydbio.2016.12.013530363527940158]Search in Google Scholar
[Kercher KW, Novitsky YW, Park A, Matthews BD, Litwin DE, Heniford BT. Laparoscopic curative resection of pheochromocytomas. Ann Surg 241, 919–928, 2005.10.1097/01.sla.0000164175.26785.06135717115912041]Search in Google Scholar
[Khatami F, Mohammadamoli M, Tavangar SM. Genetic and epigenetic differences of benign and malignant pheochromocytomas and paragangliomas (PPGLs). Endocr Regul 52, 41–54, 2018.2945391910.2478/enr-2018-000629453919]Search in Google Scholar
[Kiernan CM, Solorzano CC. Pheochromocytoma and paraganglioma: diagnosis, genetics, and treatment. Surg Oncol Clin N Am 25, 119–138, 2016.10.1016/j.soc.2015.08.006]Open DOISearch in Google Scholar
[Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M; Phaeochromocytoma Study Group in Japan. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer 21, 405–414, 2014.10.1530/ERC-13-0494]Open DOISearch in Google Scholar
[Kinney MAO, Narr BJ, Warner MA. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth 16, 359–369, 2005.10.1053/jcan.2002.124150]Search in Google Scholar
[Krestin GP, Steinbrich W, Friedmann G. Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 171, 675–680, 1989.10.1148/radiology.171.3.2717737]Search in Google Scholar
[Kudva YC, Young Jr WF, Thompson GB, Grant CS, Van Heerden JA. Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. The Endocrinologist 9, 77–80, 1999.10.1097/00019616-199903000-00002]Open DOISearch in Google Scholar
[Landsberg L. Pheochromocytomas, Paragangliomas and Disorders of the Sympathoadrenal System. Chicago, Springer, 2018.10.1007/978-3-319-77048-2]Search in Google Scholar
[Lang B, Fu B, OuYang JZ, Wang BJ, Zhang GX, Xu K, Zhang J, Wang C, Shi TP, Zhou HX, Ma X, Zhang X. Retrospective comparison of retroperitoneoscopic versus open adrenalectomy for pheochromocytoma. J Urol 179, 57–60, 2008.10.1016/j.juro.2007.08.147]Search in Google Scholar
[Lee JK. Computed Body Tomography with MRI correlation. Lippincott Williams & Wilkins, 1998.]Search in Google Scholar
[Lenders JW, Pacak K, Eisenhofer G. New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines. Ann N Y Acad Sci 970, 29–40, 2002a.10.1111/j.1749-6632.2002.tb04410.x]Search in Google Scholar
[Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287, 1427–1434, 2002b.10.1001/jama.287.11.1427]Search in Google Scholar
[Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 366, 665–675, 2005.10.1016/S0140-6736(05)67139-5]Search in Google Scholar
[Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr; Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99, 1915–1942, 2014.10.1210/jc.2014-149824893135]Search in Google Scholar
[Lenders JW, Eisenhofer G. Update on modern management of pheochromocytoma and paraganglioma. Endocrinol Metab (Seoul) 32, 152–161, 2017.2868550610.3803/EnM.2017.32.2.152550385928685506]Search in Google Scholar
[Lendvai N, Pawlosky R, Bullova P, Eisenhofer G, Patocs A, Veech RL, Pacak K. Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings. Endocrinology 155, 27–32, 2014.10.1210/en.2013-1549539863624189137]Search in Google Scholar
[Lentschener C, Gaujoux S, Thillois J, Duboc D, Bertherat J, Ozier Y, Dousset B. Increased arterial pressure is not predictive of haemodynamic instability in patients undergoing adrenalectomy for phaeochromocytoma. Acta Anaesthesiol Scand 53, 522–527, 2009.10.1111/j.1399-6576.2008.01894.x19239408]Search in Google Scholar
[Lentschener C, Gaujoux S, Tesniere A, Dousset B. Point of controversy: perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal? European Eur J Endocrinol 165, 365–373, 2011.10.1530/EJE-11-016221646289]Search in Google Scholar
[Leung K, Stamm M, Raja A, Low G. Pheochromocytoma: the range of appearances on ultrasound, CT, MRI, and functional imaging. AJR Am J Roentgeno 200, 370–378, 2013.10.2214/AJR.12.912623345359]Search in Google Scholar
[Li J, Yang CH. Improvement of preoperative management in patients with adrenal pheochromocytoma. Int J Clin Exp Med 7, 5541–5546, 2014.]Search in Google Scholar
[Liao D, Johnson RS. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26, 281–290, 2007.10.1007/s10555-007-9066-y17603752]Search in Google Scholar
[Lloyd RV, Osamura RY, International Agency for Research on Can. WHO Classification of Tumours of Endocrine Organs. Lyon, WHO, 2017.]Search in Google Scholar
[Ludwig AD, Feig DI, Brandt ML, Hicks MJ, Fitch ME, Cass DL. Recent advances in the diagnosis and treatment of pheochromocytoma in children. Am J Surg 194, 792–797, 2007.10.1016/j.amjsurg.2007.08.02818005773]Search in Google Scholar
[Lukashev D, Ohta A, Sitkovsky M. Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues. Cancer Metastasis Rev 26, 273–279, 2007.10.1007/s10555-007-9054-217404693]Search in Google Scholar
[Luo W, Hu H, Chang R, Zhong J, Knabel M, O’Meally R, Cole RN, Pandey A, Semenza GL. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145, 732–744, 2011.10.1016/j.cell.2011.03.054313056421620138]Search in Google Scholar
[Maitra A. The Endocrine System. Robbins and Cotran Pathologic Basis of Disease, Professional Edition (Eds. Kumar V, Abbas A, Fausto N, Aster J.). Phladelphia, PA, Saunders, Elsevier, 2010.10.1016/B978-1-4377-0792-2.50029-8]Search in Google Scholar
[Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40, 294–309, 2010.10.1016/j.molcel.2010.09.022314350820965423]Open DOISearch in Google Scholar
[Mak P, Leav I, Pursell B, Bae D, Yang X, Taglienti CA, Gouvin LM, Sharma VM, Mercurio AM. ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell 17, 319–332, 2010.10.1016/j.ccr.2010.02.030288182220385358]Search in Google Scholar
[Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H, Cao Y, Berkenstam A, Poellinger L. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414, 550–554, 2001.10.1038/3510708511734856]Search in Google Scholar
[Malec K, Miskiewicz P, Witkowska A, Krajewska E, Toutounchi S, Galaka Z, Piotrowski M, Kacka A, Bednarczuk T, Ambroziak U. Comparison of phenoxybenzamine and doxazosin in perioperative management of patients with pheochromocytoma. Kardiol Pol 75, 1192–1198, 2017.2871506610.5603/KP.a2017.014728715066]Search in Google Scholar
[Mallat J, Pironkov A, Destandau MS, Tavernier B. Systolic pressure variation (Deltadown) can guide fluid therapy during pheochromocytoma surgery. Can J Anaesth 50, 998–1003, 2003.10.1007/BF0301836214656776]Open DOISearch in Google Scholar
[Manger WM. The protean manifestations of pheochromocytoma. Horm Metab Res 41, 658–663, 2009.1924289910.1055/s-0028-112813919242899]Search in Google Scholar
[Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85, 637–644, 2000.10.1210/jcem.85.2.637210690869]Search in Google Scholar
[Maurea S, Cuocolo A, Reynolds JC, Neumann RD, Salvatore M. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. Q J Nucl Med 40, 365–371, 1996.9050342]Search in Google Scholar
[Mayo CH. Paroxysmal hypertension with tumor of retroperitoneal nerve: report of a case. JAMA 89, 1047–1050, 1927.10.1001/jama.1927.02690130035013]Search in Google Scholar
[Mazza A, Armigliato M, Marzola MC, Schiavon L, Montemurro D, Vescovo G, Zuin M, Chondrogiannis S, Ravenni R, Opocher G, Colletti PM, Rubello D. Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features. Endocrine 45, 469–478, 2014.10.1007/s12020-013-0007-y2381783923817839]Open DOISearch in Google Scholar
[McHenry CR. Pheochromocytoma: A clinical enigma. AACE Clinical Case Reports 3, e180–e181, 2017.10.4158/EP161587.CO]Search in Google Scholar
[McNeil AR, Blok BH, Koelmeyer TD, Burke MP, Hilton JM. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust N Z J Med 30, 648–652, 2000.10.1111/j.1445-5994.2000.tb04358.x]Search in Google Scholar
[Megias MC, Puyol DR, Rodriguez LF, Martinez GLS, Miguel PM. Feocromocitoma-paraganglioma: del diagnostico bioquímico al genetico (Pheochromocytoma-paraganglioma: Biochemical and genetic diagnosis). Nefrologia 36, 481–488, 2016.10.1016/j.nefro.2016.03.010]Search in Google Scholar
[Melicow MM. One hundred cases of pheochromocytoma (107 tumors) at the Columbia and Presbyterian Medical Center, 1926–1976: a clinicopathological analysis. Cancer 40, 1987–2004, 1977.10.1002/1097-0142(197711)40:5<1987::AID-CNCR2820400502>3.0.CO;2-R]Search in Google Scholar
[Mercado-Asis LB, Wolf KI, Jochmanova I, Taieb D. Pheochromocytoma: A genetic and diagnostic update. Endocr Pract 24, 78–90, 2018.10.4158/EP-2017-0057]Open DOISearch in Google Scholar
[Minno AM, Bennett WA, Kvale WF. Pheochromocytoma: a study of 15 cases diagnosed at autopsy. N Engl J Med 251, 959–965, 1954.10.1056/NEJM195412092512401]Search in Google Scholar
[Mirallie E, Jafari M, Pattou F, Ernst O, Huglo D, Carnaille B, Proye C. [Outcome of non-operated adrenal masses in 126 patients observed from 1986 to 1999]. Ann Chir 126, 212–220, 2001.10.1016/S0003-3944(01)00496-5]Search in Google Scholar
[Mirica A, Badarau IA, Stefanescu AM, Mirica R, Paun S, Stefan DAC, Paun DL. The role of chromogranin a in adrenal tumors. Revista de Chimie 69, 678–681, 2018.10.37358/RC.18.3.6174]Search in Google Scholar
[Mishra AK, Agarwal G, Kapoor A, Agarwal A, Bhatia E, Mishra SK. Catecholamine cardiomyopathy in bilateral malignant pheochromocytoma: successful reversal after surgery. Int J Cardiol 76, 89–90, 2000.10.1016/S0167-5273(00)00363-6]Search in Google Scholar
[Miyake H, Maeda H, Tashiro M, Suzuki K, Nagatomo H, Aikawa H, Ashizawa A, Iechika S, Moriuchi A. CT of adrenal tumors: frequency and clinical significance of low-attenuation lesions. AJR Am J Roentgenol 152, 1005–1007, 1989.10.2214/ajr.152.5.1005]Search in Google Scholar
[Moon KL Jr, Hricak H, Crooks LE, Gooding CA, Moss AA, Engelstad BL, Kaufman L. Nuclear magnetic resonance imaging of the adrenal gland: a preliminary report. Radiology 147, 155–160, 1983.10.1148/radiology.147.1.68287216828721]Search in Google Scholar
[Morrison PJ, Nevin NC. Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome). J Med Genet 33, 779–782, 1996.10.1136/jmg.33.9.779888058110507358880581]Open DOISearch in Google Scholar
[Morrison DK. MAP kinase pathways. Cold Spring Harb Perspect Biol 4, a011254, 2012.10.1101/cshperspect.a011254353634223125017]Search in Google Scholar
[Nakajima Y, Masaoka N, Sodeyama M, Tsuduki Y, Sakai M. Pheochromocytoma-related cardiomyopathy during the antepartum period in a preterm pregnant woman. J Obstet Gynaecol Res 37, 908–911, 2011.10.1111/j.1447-0756.2010.01423.x21736670]Search in Google Scholar
[Naranjo J, Dodd S, Martin YN. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth 31, 1427–1439, 2017.10.1053/j.jvca.2017.02.02328392094]Search in Google Scholar
[Naruse M, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura M, Tanaka T, Matsuda T, Imai T, Yamada M, Harada T, Kawata N, Takekoshi K. Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan. Endocr J 65, 359–371, 2018.10.1507/endocrj.EJ17-02762935382129353821]Open DOISearch in Google Scholar
[Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C, Eng C; Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346, 1459–1466, 2002.10.1056/NEJMoa02015212000816]Search in Google Scholar
[Newhouse JH. MRI of the adrenal gland. Urol Radiol 12, 1–6, 1990.233366710.1007/BF029239542333667]Search in Google Scholar
[Nomura K, Kimura H, Shimizu S, Kodama H, Okamoto T, Obara T, Takano K. Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy. J Clin Endocrinol Metab 94, 2850–2856, 2009.1947063010.1210/jc.2008-269719470630]Search in Google Scholar
[Nonaka K, Makuuchi H, Naruse Y, Kobayashi T, Goto M. Surgical excision of malignant pheochromocytoma in the left atrium. Jpn J Thorac Cardiovasc Surg 48, 126–128, 2000.10.1007/BF0321810610769996]Search in Google Scholar
[Oak S, Javid M, Callender GG, Carling T, Gibson CE. Management of pheochromocytoma in the setting of acute stroke. AACE Clinical Case Reports 4, e245–e248, 2018.10.4158/ACCR-2017-0077]Search in Google Scholar
[Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Li ST, Goldstein DS. 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 38, 6–8, 2001a.10.1161/01.HYP.38.1.611463751]Search in Google Scholar
[Pacak K, Fojo T, Goldstein DS, Eisenhofer G, Walther MM, Linehan WM, Bachenheimer L, Abraham J, Wood BJ. Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma. J Natl Cancer Inst 93, 648–649, 2001b.10.1093/jnci/93.8.648238687811309443]Open DOISearch in Google Scholar
[Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab 92, 4069–4079, 2007.1798912610.1210/jc.2007-172017989126]Search in Google Scholar
[Pacak K, Eisenhofer G, Ahlman Hk, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS; International Symposium on Pheochromocytoma. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 3, 92–102, 2007.10.1038/ncpendmet039617237836]Search in Google Scholar
[Pacak K, Wimalawansa SJ. Pheochromocytoma and paraganglioma. Endocr Pract 21, 406–412, 2015.10.4158/EP14481.RA25716634]Open DOISearch in Google Scholar
[Pamporaki C, Hamplova B, Peitzsch M, Prejbisz A, Beuschlein F, Timmers HJLM, Fassnacht M, Klink B, Lodish M, Stratakis CA, Huebner A, Fliedner S, Robledo M, Sinnott RO, Januszewicz A, Pacak K, Eisenhofer G. Characteristics of pediatric vs adult pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 102, 1122–1132, 2017.10.1210/jc.2016-382928324046546072228324046]Open DOISearch in Google Scholar
[Papadakis M, Manios A, Schoretsanitis G, Trompoukis C. Landmarks in the history of adrenal surgery. Hormones (Athens) 15, 136–141, 2016.10.1007/BF03401414]Search in Google Scholar
[Pappachan JM, Raskauskiene D, Sriraman R, Edavalath M, Hanna FW. Diagnosis and management of pheochromocytoma: a practical guide to clinicians. Curr Hypertens Rep 16, 442, 2014.2479209310.1007/s11906-014-0442-z24792093]Search in Google Scholar
[Pick L. Das Ganglioma embryonale sympathicum (Sympathoma embryonale). Berl Klin Wschnschr 49, 16–22, 1912.]Search in Google Scholar
[Pillai S, Gopalan V, Smith RA, Lam AK. Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era. Crit Rev Oncol Hematol 100, 190–208, 2016.10.1016/j.critrevonc.2016.01.02226839173]Open DOISearch in Google Scholar
[Plesoianu CE, Andriescu G, Salaru D, Georgescu CA. The relationship between biochemical variables and the quality of life in patients with chronic heart failure. Rev Chim (Bucharest), 68, 2452–2458, 2017.10.37358/RC.17.10.5904]Search in Google Scholar
[Plouin PF, Chatellier G, Fofol I, Corvol P. Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension 29, 1133–1139, 1997.914967810.1161/01.HYP.29.5.11339149678]Search in Google Scholar
[Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab 86, 1480–1486, 2001.10.1210/jc.86.4.1480]Search in Google Scholar
[Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gimenez-Roqueplo AP, Lenders JW, Lussey-Lepoutre C, Steichen O; Guideline Working Group. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol 174, G1–G10, 2016.10.1530/EJE-16-003327048283]Search in Google Scholar
[Pogorzelski R, Toutounchi S, Krajewska E, Fiszer P, Lykowski M, Zapala L, Szostek M, Jakuczun W, Pachucki J, Skorski M. The effect of surgical treatment of phaeochromocytoma on concomitant arterial hypertension and diabetes mellitus in a single-centre retrospective study. Cent European J Uro 67, 361–365, 2014.10.5173/ceju.2014.04.art9431089625667755]Search in Google Scholar
[Pollard P, Briere J, Alam N, Barwell J, Barclay E, Wortham N, Hunt T, Mitchell M, Olpin S, Moat SJ, Hargreaves IP, Heales SJ, Chung YL, Griffiths JR, Dalgleish A, McGrath JA, Gleeson MJ, Hodgson SV, Poulsom R, Rustin P, Tomlinson IP. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14, 2231–2239, 2005.10.1093/hmg/ddi22715987702]Open DOISearch in Google Scholar
[Poopalalingam R, Chin EY. Rapid preparation of a patient with pheochromocytoma with labetolol and magnesium sulfate. Can J Anaesth 48, 876–880, 2001.10.1007/BF030173531160634411606344]Open DOISearch in Google Scholar
[Pourian M, Mostafazadeh DB, Soltani A. Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms. J Diabetes Metab Disord 15, 11, 2016.10.1186/s40200-016-0226-x479717626998444]Search in Google Scholar
[Press D, Akyuz M, Dural C, Aliyev S, Monteiro R, Mino J, Mitchell J, Hamrahian A, Siperstein A, Berber E. Predictors of recurrence in pheochromocytoma. Surgery 156, 1523–1528, 2014.10.1016/j.surg.2014.08.04425456947]Search in Google Scholar
[Prinz RA. A comparison of laparoscopic and open adrenalectomies. Arch Surg 130, 489–494, 1995.10.1001/archsurg.1995.014300500390067748086]Search in Google Scholar
[Proye C, Fossati P, Fontaine P, Lefebvre J, Decoulx M, Wemeau JL, Dewailly D, Rwamasirabo E, Cecat P. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 100, 1154–1162, 1986.]Search in Google Scholar
[Raimundo N, Baysal BE, Shadel GS. Revisiting the TCA cycle: signaling to tumor formation. Trends Mol Med 17, 641–649, 2011.10.1016/j.molmed.2011.06.00121764377320530221764377]Open DOISearch in Google Scholar
[Ramachandran R, Rewari V. Current perioperative management of pheochromocytomas. Indian J Urol 33, 19–25, 2017.28197025]Search in Google Scholar
[Rao N, Ramachandran R, Tandon N, Singh P, Kumar R. Laparoscopic adrenalectomy for pheochromocytoma-does size matter? A single surgeon comparative study. Transl Androl Urol 5, 780–783, 2016.2778543610.21037/tau.2016.08.10507119127785436]Search in Google Scholar
[Renard J, Clerici T, Licker M, Triponez F. Pheochromocytoma and abdominal paraganglioma. J Visc Surg 148, e409–e416, 2011.10.1016/j.jviscsurg.2011.07.00321862435]Search in Google Scholar
[Reyes HA, Paquin JJ, Harris DM. Pheochromocytoma, “the Great Masquerader,” Presenting as Severe Acute Decompensated Heart Failure in a Young Patient. Case Rep Cardiol 2018, 8767801, 2018.10.1155/2018/8767801594918829854474]Search in Google Scholar
[Robbins SL, Kumar V. Basic Pathology, 4th Edition. Philadelphia, Saunders, 1987.10.1097/00006324-198708000-00014]Search in Google Scholar
[Rossitti HM, Soderkvist P, Gimm O. Extent of surgery for phaeochromocytomas in the genomic era. Br J Surg 105, e84–e98, 2018.10.1002/bjs.1074429341163]Search in Google Scholar
[Saffarini O. Open versus laparoscopic adrenalectomy for Pheochromocytoma. Diploma In Minimal Access Surgery, Laparoscopy Hospital, New Delhi, India, 2007.]Search in Google Scholar
[Sanford EL, Hickey T, Lu J. Acute Takotsubo cardiomyopathy during elective hernia repair in a patient with previously resected pheochromocytoma. J Cardiothorac Vasc Anesth 29, 1596–1598, 2015.10.1053/j.jvca.2014.12.00125813227]Search in Google Scholar
[Scheffler IE. Mitochondria. New Jersey, Wiley and Sons, Inc., 2008.]Search in Google Scholar
[Schenker JG, Granat M. Phaeochromocytoma and pregnancy-an updated appraisal. Aust N Z J Obstet Gynaecol 22, 1–10, 1982.10.1111/j.1479-828X.1982.tb01388.x]Search in Google Scholar
[Scholten A, Cisco RM, Vriens MR, Cohen JK, Mitmaker EJ, Liu C, Tyrrell JB, Shen WT, Duh QY. Pheochromocytoma crisis is not a surgical emergency. J Clin Endocrinol Metab 98, 581–591, 2013.10.1210/jc.2012-302023284003]Open DOISearch in Google Scholar
[Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, Worden FP. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12, 667–680, 2005.10.1677/erc.1.010291617219916172199]Open DOISearch in Google Scholar
[Schultz CL, Haaga JR, Fletcher BD, Alfidi RJ, Schultz MA. Magnetic resonance imaging of the adrenal glands: a comparison with computed tomography. AJR Am J Roentgenol 143, 1235–1240, 1984.10.2214/ajr.143.6.12356333793]Search in Google Scholar
[Schulz C, Eisenhofer G, Lehnert H. Principles of catecholamine biosynthesis, metabolism and release. Front Horm Res. 31, 1–25, 2004.10.1159/00007465614674302]Search in Google Scholar
[Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7, 77–85, 2005.10.1016/j.ccr.2004.11.0221565275115652751]Open DOISearch in Google Scholar
[Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3, 721–732, 2003.10.1038/nrc118713130303]Search in Google Scholar
[Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, 625–634, 2010.10.1038/onc.2009.441296916819946328]Open DOISearch in Google Scholar
[Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 148, 399–408, 2012.10.1016/j.cell.2012.01.021343754322304911]Search in Google Scholar
[Shawar L, Svec F. Pheochromocytoma with elevated metanephrines as the only biochemical finding. J La State Med Soc 148, 535–538, 1996.]Search in Google Scholar
[Shulkin BL, Ilias I, Sisson JC, Pacak K. Current trends in functional imaging of pheochromocytomas and paragangliomas. Ann N Y Acad Sci 1073, 374–382, 2006.10.1196/annals.1353.04117102106]Search in Google Scholar
[Siddiqi HK, Yang HY, Laird AM, Fox AC, Doherty GM, Miller BS, Gauger PG. Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas. Surgery 152, 1027–1036, 2012.10.1016/j.surg.2012.08.02323158177]Search in Google Scholar
[Sinclair D, Shenkin A, Lorimer A. Normal catecholamine production in a patient with a paroxysmally secreting phaeochromocytoma. Ann Clin Biochem 28, 417–419, 1991.10.1177/0004563291028004201892355]Open DOISearch in Google Scholar
[Soltani A, Pourian M, Davani BM. Correction to: Does this patient have Pheochromocytoma? a systematic review of clinical signs and symptoms. J Diabetes Metab Disord 16, 42, 2017.10.1186/s40200-017-0324-4564405929046871]Search in Google Scholar
[Stein PP, Black HR. A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution‘s experience. Medicine (Baltimore) 70, 46–66, 1991.10.1097/00005792-199101000-000041988766]Open DOISearch in Google Scholar
[Steinsapir J, Carr AA, Prisant LM, Bransome ED Jr. Metyrosine and pheochromocytoma. Arch Intern Med 157, 901–906, 1997.10.1001/archinte.157.8.901]Search in Google Scholar
[Sternberg SS, Antonioli DA, Carter D, Mills SE, Oberman HA. Diagnostic Surgical Pathology, 3rd ed., Vol. 2. Philadelphia, PA, USA, Lippincott, Williams & Wilkins, 1999.]Search in Google Scholar
[Stewart MF, Reed P, Weinkove C, Moriarty KJ, Ralston AJ. Biochemical diagnosis of phaeochromocytoma: two instructive case reports. J Clin Pathol 46, 280–282, 1993.10.1136/jcp.46.3.28084634265011898463426]Open DOISearch in Google Scholar
[Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 56, 354–360, 1981.]Search in Google Scholar
[Swietach P, Vaughan-Jones RD, Harris AL. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 26, 299–310, 2007.10.1007/s10555-007-9064-017415526]Open DOISearch in Google Scholar
[Tanaka M, Tokuda N, Koga H, Kimoto Y, Naito S. Laparoscopic adrenalectomy for pheochromocytoma: comparison with open adrenalectomy and comparison of laparoscopic surgery for pheochromocytoma versus other adrenal tumors. J Endourol 14, 427–431, 2000.10.1089/end.2000.14.4271095856510958565]Open DOISearch in Google Scholar
[Thanapaalasingham K, Pollmann AS, Schelew B. Failure of metyrosine therapy for preoperative management of pheochromocytoma: a case report. Can J Anaesth 62, 1303–1307, 2015.2636280010.1007/s12630-015-0480-226362800]Search in Google Scholar
[Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26, 551–566, 2002.10.1097/00000478-200205000-0000211979086]Open DOISearch in Google Scholar
[Thomson BN, Moulton CA, Davies M, Banting SW. Laparoscopic adrenalectomy for phaeochromocytoma: with caution. ANZ J Surg 74, 429–433, 2004.10.1111/j.1445-1433.2004.03024.x1519147315191473]Open DOISearch in Google Scholar
[Toledo RA, Burnichon N, Cascon A, Benn DE, Bayley JP, Welander J, Tops CM, Firth H, Dwight T Ercolino T1, Mannelli M, Opocher G, Clifton-Bligh R, Gimm O, Maher ER, Robledo M, Gimenez-Roqueplo AP, Dahia PL, NGS in PPGL (NGSnPPGL) Study Group. Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol 13, 233–247, 2017.10.1038/nrendo.2016.18527857127]Open DOISearch in Google Scholar
[Toledo R, Jimenez C. Recent advances in the management of malignant pheochromocytoma and paraganglioma: focus on tyrosine kinase and hypoxia-inducible factor inhibitors. F1000Res 7, pii: F1000 Faculty Rev-1148, 2018.10.12688/f1000research.13995.1]Search in Google Scholar
[Toniato A, Piotto A, Pagetta C, Bernante P, Pelizzo M. Technique and results of laparoscopic adrenalectomy. Langenbecks Arch Surg 386, 200–203, 2001.10.1007/s00423010023111382322]Search in Google Scholar
[Toniato A, Boschin IM, Opocher G, Guolo A, Pelizzo M, Mantero F. Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment? Surgery 141, 723–727, 2007.10.1016/j.surg.2006.10.01217560248]Search in Google Scholar
[Townsend CM, Beauchanp RD, Evers BM, Mattox KL. Sabiston Textbook of Surgery, 19th Ed., Elsevier Publishers, 2012.]Search in Google Scholar
[Tschuor C, Sadri H, Clavien PA. Pheochromocytoma crisis. Clin Case Rep 2, 14, 2014.10.1002/ccr3.6418476625356229]Search in Google Scholar
[Turchini J, Gill AJ, Tischler AS. Pathology of Pheochromocytoma and Paraganglioma. In: Pheochromocytomas, Paragangliomas and Disorders of the Sympathoadrenal System (ed. Landsberg L). Humana Press, Springer, 2018.10.1007/978-3-319-77048-2_2]Search in Google Scholar
[Udelsman R. Adrenal. In: Surgery, Basic Science and Clinical Evidence (eds. Norton JA, Bollinger RR). Bollinger, Springer, 2001.]Search in Google Scholar
[Unger N, Hinrichs J, Deutschbein T, Schmidt H, Walz M, Mann K, Petersenn S. Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal mass. Exp Clin Endocrinol Diabetes 120, 494–500, 2012.10.1055/s-0032-130900722696168]Search in Google Scholar
[van Berkel A, Lenders JW, Timmers HJ. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma. Eur J Endocrinol 170, R109–R119, 2014.10.1530/EJE-13-088224347425]Search in Google Scholar
[van der Weerd K, van Noord C, Loeve M, Knapen M, Visser W, de Herder W, Franssen G, van der Marel C, Feelders R. Endocrinology in pregnancy: Pheochromocytoma in pregnancy: case series and review of literature. Eur J Endocrinol 177, R49–R58, 2017.10.1530/EJE-16-092028381449]Search in Google Scholar
[von Schlegel GG. Neurofibromatose recklinghausen und phaochromocytom. Schweiz Med Wochenschr 90, 31–39, 1960.]Search in Google Scholar
[Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 95, 2023–2037, 2010.10.1210/jc.2009-283020215394]Search in Google Scholar
[Wang Y, Liu Y, Malek SN, Zheng P, Liu Y. Targeting HIF1α eliminates cancer stem cells in hematological malignancies. Cell Stem Cell 8, 399–411, 2011.10.1016/j.stem.2011.02.006308459521474104]Search in Google Scholar
[Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol 8, 519–530, 1927.10.1085/jgp.8.6.519214082019872213]Search in Google Scholar
[Weiner MM, Asher DI, Augoustides JG, Evans AS, Patel PA, Gutsche JT, Mookadam F, Ramakrishna H. Takotsubo cardiomyopathy: A clinical update for the cardiovascular anesthesiologist. J Cardiothorac Vasc Anesth 31, 334–344, 2017.2754683110.1053/j.jvca.2016.06.00427546831]Search in Google Scholar
[Weingarten TN, Cata JP, O‘Hara JF, Prybilla DJ, Pike TL, Thompson GB, Grant CS, Warner DO, Bravo E, Sprung J. Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology 76, 508.e6–508.e11, 2010.10.1016/j.urology.2010.03.03220546874]Search in Google Scholar
[Weinstein JN, Collisson EA, Mills GB, Shaw KRM, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM, Cancer Genome Atlas Research Network. The cancer genome atlas pan-cancer analysis project. Nat Genet 45, 1113–1120, 2013.10.1038/ng.2764391996924071849]Open DOISearch in Google Scholar
[Welander J, Larsson C, Backdahl M, Hareni N, Sivler T, Brauckhoff M, Soderkvist P, Gimm O. Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas. Hum Mol Genet 21, 5406–5416, 2012.10.1093/hmg/dds40223010473]Open DOISearch in Google Scholar
[Welbourn RB. Early surgical history of phaeochromocytoma. Br J Surg 74, 594–596, 1987.10.1002/bjs.18007407173304519]Search in Google Scholar
[Wiese KE, Nusse R, van Amerongen R. Wnt signalling: conquering complexity. Development 145, dev165902, 2018.10.1242/dev.16590229945986]Search in Google Scholar
[Wiesener MS, Jurgensen JS, Rosenberger C, Scholdge CK, Horstrup JH, Warnecke C, Mandriota S, Bechmann I, Frei UA, Pugh CW, Ratcliffe PJ, Bachmann S, Maxwell PH, Eckardt KU. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 17, 271–273, 2003.10.1096/fj.02-0445fje1249053912490539]Open DOISearch in Google Scholar
[Wing LA, Conaglen JV, Meyer-Rochow GY, Elston MS. Paraganglioma in pregnancy: a case series and review of the literature. J Clin Endocrinol Metab 100, 3202–3209, 2015.10.1210/jc.2015-212226083822]Search in Google Scholar
[Wyszynska T, Cichocka E, Wieteska-Klimczak A, Jobs K, Januszewicz P. A single pediatric center experience with 1025 children with hypertension. Acta Paediatr 81, 244–246, 1992.10.1111/j.1651-2227.1992.tb12213.x1511199]Search in Google Scholar
[Yu R, Wei M. False positive test results for pheochromocytoma from 2000 to 2008. Exp Clin Endocrinol Diabetes 118, 577–585, 2010.10.1055/s-0029-123769919998239]Search in Google Scholar
[Yumi H, Guidelines Committee of the Society of American Gastrointestinal and Endoscopic Surgeons. Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy: this statement was reviewed and approved by the Board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), September 2007. It was prepared by the SAGES Guidelines Committee. Surg Endosc 22, 849–861, 2008.10.1007/s00464-008-9758-618288533]Search in Google Scholar
[Zhikrivetskaya SO, Snezhkina AV, Zaretsky AR, Alekseev BY, Pokrovsky AV, Golovyuk AL, Melnikova NV, Stepanov OA, Kalinin DV, Moskalev AA, Krasnov GS, Dmitriev AA, Kudryavtseva AV. Molecular markers of paragangliomas/pheochromocytomas. Oncotarget 8, 25756–25782, 2017.2818700110.18632/oncotarget.15201]Search in Google Scholar
[Zhu H, Bunn HF. Oxygen sensing and signaling: impact on the regulation of physiologically important genes. Respir Physiol 115, 239–247, 1999.10.1016/S0034-5687(99)00024-9]Search in Google Scholar